Certain insurance plans are legally required to cover benefits for addiction treatment under the Affordable Care Act (ACA). A new report by Center on Addiction shows that ACA Plans sold in many states in 2017 did not comply with these requirements.
A study of young adults who misuse opioids finds that although women have a higher prevalence of potential risk factors for overdose such as mental health issues and sexual victimization, their lifetime prevalence of overdose is similar to that of men.
People with a substance use disorder (SUD) had lower hospitalizations after working with a recovery coach, a study presented at the recent American Society of Addiction Medicine annual meeting suggests. People with a SUD are almost twice as likely to be readmitted to the hospital compared to those without.
Most young adults who use illicit drugs are willing to test them for the presence of fentanyl by using a rapid test strip, a study presented at the recent American Society of Addiction Medicine annual meeting suggests.
The proportion of inmates in jails with a moderate to severe stimulant use disorder—including addiction to methamphetamine—has surged in recent years, a study presented at the recent American Society of Addiction Medicine annual meeting suggests.
Researchers at New York University are studying whether providing the opioid-addiction medicine extended-release naltrexone (Vivitrol) to individuals when they leave jail reduces their risk of relapse and overdose.
A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
There seem to be a growing number of cases of high amounts of fluid in the lungs following administration of the opioid overdose antidote naloxone, experts said at a recent meeting of the New York Society of Addiction Medicine annual meeting.
The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
A growing body of research points to the relationship between alcohol and suicide. Taking steps to reduce the availability of alcohol may help to reduce the number of suicides, says Raul Caetano, M.D., Ph.D., Senior Research Scientist at the Prevention Research Center of the Pacific Institute for Research and Evaluation in Oakland, California.
Many doctors, even those who specialize in addiction treatment, do not have a good understanding of Alcoholics Anonymous (AA) and its benefits for people struggling to give up drinking, says Marc Galanter, M.D., Founding Director of the Division of Alcoholism and Drug Abuse at NYU Langone Medical Center.
While there have been substantial gains on the issue of parity – making addiction and mental health coverage equal to physical health coverage – much work still needs to be done, especially for children, according to Ron Manderscheid, Ph.D., Executive Director of the National Association of County Behavioral Health and Developmental Disability Directors and the National Association for Rural Mental Health.
A new review of studies from around the world finds young people who have greater exposure to alcohol marketing appear to be more likely subsequently to initiate alcohol use and engage in binge and hazardous drinking.
Setting new household rules for teens in treatment for a substance use disorder can be challenging for parents. But it is important because research shows that teens do take their parents’ attitudes, opinions and beliefs into account when they make choices about substance use, says Christopher Hammond, MD, of Johns Hopkins Hospital.
In the past year, federal and state policymakers have taken a number of steps to combat synthetic drugs, also known as “novel psychoactive substances,” according to Jonathan Woodruff, Senior Legislative Attorney at the National Alliance for Model State Drug Laws.
All patients on long-term opioid treatment should be co-prescribed the opioid overdose antidote naloxone, even if they are not considered to be at high risk of an opioid overdose, according to the director of the University of New Mexico Pain Center.